original ) (raw )Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a …
Mark Connors
Journal of …, 2007
View PDFchevron_right
Analysis of Total Human Immunodeficiency Virus (HIV)-Specific CD4+ and CD8+ T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection
Joseph Casazza
Journal of Virology, 2001
View PDFchevron_right
Clinical Outcome of HIV Viraemic Controllers and Noncontrollers with Normal CD4 Counts Is Exclusively Determined by Antigen-Specific CD8+ T-Cell-Mediated HIV Suppression
Pokrath Hansasuta
PloS one, 2015
View PDFchevron_right
Human immunodeficiency virus type I-specific CD8+ T cell subset abnormalities in chronic infection persist through effective antiretroviral therapy
Julia Pohling
BMC Infectious Diseases, 2010
View PDFchevron_right
Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+ T Cells Is Associated with Diminished Interleukin2 (IL2) Production and Is Recovered by Exogenous IL2
Christiana Iyasere
Journal of Virology, 2003
View PDFchevron_right
T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy
Elizabeth Sinclair
The Journal of Infectious Diseases, 2003
View PDFchevron_right
HIV-specific CD4+ T cells and viremia: who's in control?
Christine Jansen
Trends in Immunology, 2006
View PDFchevron_right
Discordant Outcomes following Failure of Antiretroviral Therapy Are Associated with Substantial Differences in Human Immunodeficiency Virus-Specific Cellular Immunity
Rodney Phillips
Journal of Virology, 2003
View PDFchevron_right
The Relationship between T Cell Proliferative Responses and Plasma Viremia during Treatment of Human Immunodeficiency Virus Type 1 Infection with Combination Antiretroviral Therapy
Gabriel Alejandro Lopz Ortiz
The Journal of Infectious Diseases, 2000
View PDFchevron_right
The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination …
Gabriel Alejandro Lopz Ortiz
Journal of Infectious …, 2000
View PDFchevron_right
Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection
Jean-Marc Doisne
The Journal of infectious diseases, 2003
View PDFchevron_right
Strong Human Immunodeficiency Virus (HIV)–Specific CD4 + T Cell Responses in a Cohort of Chronically Infected Patients Are Associated with Interruptions in Anti‐HIV Chemotherapy
Gilla Kaplan
The Journal of Infectious Diseases, 2000
View PDFchevron_right
The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation
Wim Trypsteen
Frontiers in Immunology
View PDFchevron_right
HIV-Specific CD4+ T Cells May Contribute to Viral Persistence in HIV Controllers
Peter Hunt
Clinical Infectious Diseases, 2011
View PDFchevron_right
Rapid whole blood analysis of virus-specific CD4 and CD8 T cell responses in persistent HIV infection
A. Meyerhans
AIDS, 2000
View PDFchevron_right
V 2V 2 T Cells are Skewed Toward a Terminal Differentiation Phenotype in Untreated HIV Infection
Julian Schulze zur Wiesch
Journal of Infectious Diseases, 2013
View PDFchevron_right
Immunological evaluation of human immunedeficiency virus infected individuals by flow cytometry
Ivan Neves
Memórias do Instituto Oswaldo Cruz, 2000
View PDFchevron_right
Relationship between T Cell Activation and CD4+T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy
Elizabeth Sinclair
The Journal of Infectious Diseases, 2008
View PDFchevron_right
HIV-specific T cell responses are highly stable on antiretroviral therapy
Joann Kuruc
Molecular Therapy - Methods & Clinical Development
View PDFchevron_right
Different Immunological Phenotypes Associated with Preserved CD4+ T Cell Counts in HIV-Infected Controllers and Viremic Long Term Non-Progressors
Hans Madsen
PLoS ONE, 2013
View PDFchevron_right
Virological Outcome after Structured Interruption of Antiretroviral Therapy for Human Immunodeficiency Virus Infection Is Associated with the Functional Profile of Virus-Specific CD8+ T Cells
Catherine Rehm
Journal of Virology, 2008
View PDFchevron_right
Immune signatures for HIV-1 and HIV-2 induced CD4+T cell dysregulation in an Indian cohort
sukeshani salwe
2019
View PDFchevron_right
HIV Controllers Maintain a Population of Highly Efficient Th1 Effector Cells in Contrast to Patients Treated in the Long Term
Benoît Vingert
Journal of Virology, 2012
View PDFchevron_right
Evaluation of the Pathogenesis of Decreasing CD4 + T Cell Counts in Human Immunodeficiency Virus Type 1–Infected Patients Receiving Successfully Suppressive Antiretroviral Therapy
Robin Dewar
The Journal of Infectious Diseases, 2009
View PDFchevron_right
Antiretroviral therapy-induced dominant interleukin-2 HIV-1 Gag CD4+ T cell response: evidence of functional recovery of HIV-1-specific CD4+ T cells
eleni choremi
Scandinavian journal of immunology, 2011
View PDFchevron_right
Residual Viral Replication during Antiretroviral Therapy Boosts Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses in Subjects Treated Early after Infection
Marie Larsson
Journal of Virology, 2002
View PDFchevron_right
Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8+ T-cell responses in subjects treated early after …
Gabriel Alejandro Lopz Ortiz
Journal of …, 2002
View PDFchevron_right
Defective Human Immunodeficiency Virus-Specific CD8 + T-Cell Polyfunctionality, Proliferation, and Cytotoxicity Are Not Restored by Antiretroviral Therapy
Mark Connors
Journal of Virology, 2009
View PDFchevron_right
HIV Controllers With Different Viral Load Cutoff Levels Have Distinct Virologic and Immunologic Profiles
Fernanda Cortes
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2015
View PDFchevron_right
Determinants of CD4 + T Cell Recovery during Suppressive Antiretroviral Therapy: Association of Immune Activation, T Cell Maturation Markers, and Cellular HIV‐1 DNA
Susanne May
The Journal of Infectious Diseases, 2006
View PDFchevron_right